Lisata Therapeutics's total assets for Q2 2025 were $25.16M, a decrease of -13.18% from the previous quarter. LSTA total liabilities were $4.38M for the fiscal quarter, a 13.04% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.